Securities fraud
Search documents
LRN CLASS REMINDER: Stride, Inc. Investors with Losses are Reminded to Contact BFA Law before the Imminent January 12 Securities Class Action Deadline
Newsfile· 2025-11-28 13:18
Core Viewpoint - A class action lawsuit has been filed against Stride, Inc. for securities fraud, following significant stock drops attributed to alleged violations of federal securities laws [1][3]. Company Overview - Stride, Inc. is an education technology company that provides an online platform for students across the U.S. [4]. Allegations and Stock Impact - The lawsuit claims that Stride inflated enrollment numbers by retaining "ghost students" to secure state funding and ignored compliance requirements, leading to poor customer experiences and higher withdrawal rates [4][5]. - Following the filing of the complaint on September 14, 2025, Stride's stock dropped by $18.60 per share, or over 11%, from $158.36 to $139.76 [5]. - On October 28, 2025, Stride acknowledged that poor customer experiences led to an estimated 10,000-15,000 fewer enrollments, resulting in a further stock drop of $83.48 per share, or more than 54%, from $153.53 to $70.05 [6]. Legal Proceedings - Investors have until January 12, 2026, to request to lead the case in the U.S. District Court for the Eastern District of Virginia [3]. - The lawsuit is titled MacMahon v. Stride, Inc., et al., No. 1:25-cv-02019 [3]. Investor Actions - Investors are encouraged to submit their information to the law firm representing the class action, with no upfront costs for shareholders [8].
MLTX CLASS REMINDER: MoonLake Immunotherapeutics Investors are Reminded to Contact BFA Law before the Imminent December 15 Securities Class Action Deadline
Newsfile· 2025-11-28 13:18
MLTX CLASS REMINDER: MoonLake Immunotherapeutics Investors are Reminded to Contact BFA Law before the Imminent December 15 Securities Class Action DeadlineNovember 28, 2025 8:18 AM EST | Source: Bleichmar Fonti & AuldNew York, New York--(Newsfile Corp. - November 28, 2025) - Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against MoonLake Immunotherapeutics (NASDAQ: MLTX) and certain of the Company's senior executives for potential violations of t ...
KMX CLASS REMINDER: CarMax, Inc. Investors with Losses are Reminded to Contact BFA Law before the Imminent January 2 Securities Class Action Deadline
Newsfile· 2025-11-28 13:18
KMX CLASS REMINDER: CarMax, Inc. Investors with Losses are Reminded to Contact BFA Law before the Imminent January 2 Securities Class Action DeadlineNovember 28, 2025 8:18 AM EST | Source: Bleichmar Fonti & AuldNew York, New York--(Newsfile Corp. - November 28, 2025) - Leading securities law firm Bleichmar Fonti & Auld LLP announces that a class action lawsuit has been filed against CarMax, Inc. (NYSE: KMX) and certain of the Company's senior executives for securities fraud after a significant ...
JHX CLASS REMINDER: James Hardie Industries plc Investors with Losses are Reminded to Contact BFA Law before the Imminent December 23 Securities Class Action Deadline
Newsfile· 2025-11-28 13:18
Core Viewpoint - A class action lawsuit has been filed against James Hardie Industries plc for securities fraud, following a significant stock drop attributed to potential violations of federal securities laws [1][3]. Group 1: Lawsuit Details - Investors have until December 23, 2025, to request to lead the case in the U.S. District Court for the Northern District of Illinois [3]. - The lawsuit claims violations under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 on behalf of investors in James Hardie common stock [3]. Group 2: Company Background - James Hardie is a producer and marketer of high-performance fiber cement building solutions, primarily used in external siding for the residential building industry in the U.S. and Canada [4]. Group 3: Allegations of Fraud - During the relevant period, James Hardie misrepresented the strength and momentum of its North American fiber cement segment, claiming sustainable customer demand when, in fact, sales were driven by inventory loading by channel partners [5]. - The company reported a 12% decline in North American fiber cement sales during the quarter, revealing that customers were destocking to return to normal inventory levels [6]. Group 4: Stock Performance - Following the revelation of declining sales, James Hardie's stock price fell by $9.79 per share, a decrease of over 34%, from $28.43 on August 19, 2025, to $18.64 on August 20, 2025 [6]. Group 5: Management Changes - On November 17, 2025, it was announced that Rachel Wilson would step down from her role as CFO of James Hardie [7].
FCX CLASS REMINDER: Freeport-McMoRan Inc. Investors with Losses are Reminded to Contact BFA Law before the Imminent January 12 Securities Class Action Deadline
Newsfile· 2025-11-28 13:18
FCX CLASS REMINDER: Freeport-McMoRan Inc. Investors with Losses are Reminded to Contact BFA Law before the Imminent January 12 Securities Class Action DeadlineNovember 28, 2025 8:18 AM EST | Source: Bleichmar Fonti & AuldNew York, New York--(Newsfile Corp. - November 28, 2025) - Leading securities law firm Bleichmar Fonti & Auld LLP announces that a class action lawsuit has been filed against Freeport-McMoRan Inc. (NYSE: FCX) and certain of the Company's senior executives for securities fraud ...
Halper Sadeh LLC Encourages SEE, EXAS, MRSN Shareholders to Contact the Firm to Discuss Their Rights
Globenewswire· 2025-11-27 23:48
Core Points - Halper Sadeh LLC is investigating potential violations of federal securities laws and breaches of fiduciary duties related to the sale of Sealed Air Corporation to funds affiliated with CD&R for $42.15 per share in cash [1] - Exact Sciences Corporation is being sold to Abbott for $105.00 per common share in cash, and Mersana Therapeutics, Inc. is being sold to Day One Biopharmaceuticals, Inc. [2] - The firm may seek increased consideration for shareholders, additional disclosures, or other relief on behalf of shareholders, operating on a contingent fee basis [3] Company Investigations - Sealed Air Corporation's sale price is $42.15 per share in cash [1] - Exact Sciences Corporation's sale price is $105.00 per common share in cash [2] - Mersana Therapeutics, Inc. is involved in a sale to Day One Biopharmaceuticals, Inc. [2] Legal Rights and Options - Shareholders are encouraged to contact Halper Sadeh LLC to discuss their legal rights and options free of charge [4] - The firm represents investors globally who have experienced securities fraud and corporate misconduct [4]
PRMB Lawsuit: Primo Brands Investors Must Act by Jan. 12 Deadline over Botched Merger, CEO Exit
Globenewswire· 2025-11-27 18:34
Core Viewpoint - The lawsuit against Primo Brands Corporation alleges that the company misled investors regarding the successful integration of its merger, which was actually fraught with significant operational issues, leading to a substantial decline in stock value [2][4][5]. Allegations and Facts - The lawsuit claims that executives of Primo Brands assured investors that the merger was progressing well and would enhance growth, despite the existence of undisclosed technological and service problems [4][6]. - The situation escalated on November 6, 2025, when the company announced a leadership change and acknowledged that they had "probably moved too far too fast" in the integration process, resulting in a 36% drop in stock price as investors became aware of the operational failures [5][9]. Financial Impact - Following the November 6, 2025, disclosure of operational issues, the stock of Primo Brands fell approximately 36%, and the company was forced to revise its revenue forecasts for 2025 downward [5][9]. Next Steps for Investors - Investors who purchased securities of Primo Brands or its predecessor during the Class Period (June 17, 2024 – November 6, 2025) and experienced losses may be eligible to serve as Lead Plaintiff, with a deadline to file by January 12, 2026 [7][9].
Stride (LRN) Investor Lawsuit: Investors Face Jan. 12 Lead Plaintiff Deadline
Globenewswire· 2025-11-27 18:32
Core Viewpoint - The lawsuit against Stride, Inc. alleges that the company misled investors regarding its operational health and compliance, leading to a significant stock decline of over 54% following damaging disclosures [1][4]. Summary by Relevant Sections Allegations - Stride is accused of inflating enrollment figures by retaining "ghost students" and failing to disclose operational and compliance failures, which artificially inflated its stock price [2][4]. - The company allegedly ignored compliance by increasing student-to-teacher ratios beyond required limits and neglecting mandated special education services [6]. Key Events - A public report on September 14, 2025, revealed a lawsuit by Gallup-McKinley school district alleging fraud, causing Stride's stock to drop by 11% [6]. - On October 28, 2025, Stride announced severe operational issues due to a failed platform upgrade, resulting in a stock crash of over 54% in one day [6]. Investor Information - Investors who purchased Stride securities between October 22, 2024, and October 28, 2025, and suffered losses may be eligible to serve as Lead Plaintiff in the class action lawsuit [5][6]. - The deadline for filing a motion for Lead Plaintiff is January 12, 2026 [6]. Whistleblower Information - Individuals with non-public information regarding Stride are encouraged to assist in the investigation or utilize the SEC Whistleblower program, which offers rewards up to 30% of any successful recovery [7].
SFM INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Sprouts Farmers Market, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
Globenewswire· 2025-11-27 17:00
Core Viewpoint - A class action lawsuit has been filed against Sprouts Farmers Market, Inc. for alleged violations of federal securities laws during the specified class period [1][2]. Group 1: Lawsuit Details - The lawsuit seeks to recover damages for investors who purchased Sprouts securities between June 4, 2025, and October 29, 2025 [2]. - Allegations include that Sprouts' growth potential for fiscal year 2025 was overstated and that the company misled investors about the resilience of its customer base against macroeconomic pressures [3]. - It is claimed that the company concealed the potential for a significant slowdown in sales growth due to a more cautious consumer, which would negate any perceived benefits from market conditions [3]. Group 2: Next Steps for Investors - Investors who suffered losses in Sprouts have until January 26, 2026, to request appointment as lead plaintiff in the case [4]. - A copy of the complaint can be reviewed on the law firm's website [4]. Group 3: Legal Representation - The law firm representing the investors operates on a contingency fee basis, meaning they will only collect fees if the case is successful [5]. - Bronstein, Gewirtz & Grossman, LLC is noted for its experience in securities fraud class actions and has recovered significant amounts for investors [6].
STUB INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that StubHub Holdings, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
Globenewswire· 2025-11-27 17:00
Core Viewpoint - A class action lawsuit has been filed against StubHub Holdings, Inc. for alleged violations of federal securities laws related to its September 17, 2025 IPO [1][2]. Group 1: Lawsuit Details - The lawsuit seeks to recover damages for investors who purchased StubHub securities during the IPO [2]. - The Complaint alleges that the Registration Statement was materially false and misleading, omitting critical information about changes in payment timing to vendors and their adverse impact on free cash flow [3]. - It is claimed that the misleading reports on free cash flow and positive statements about the Company's business operations lacked a reasonable basis [3]. Group 2: Next Steps for Investors - Investors who suffered losses in StubHub have until January 23, 2026, to request appointment as lead plaintiff in the case [4]. - Participation in any recovery does not require serving as lead plaintiff [4]. Group 3: Legal Representation - Bronstein, Gewirtz & Grossman, LLC operates on a contingency fee basis, meaning they will only seek reimbursement for expenses and fees if successful [5]. - The firm has a history of recovering hundreds of millions of dollars for investors in securities fraud class actions [6].